Cadrenal Therapeutics Starts Strategic Review, Hires Advisor

Cadrenal Therapeutics has initiated a formal strategic process to evaluate various options including licensing, asset sales, partnerships, portfolio deals, or business combinations. The company has retained Tungsten Advisors as its exclusive strategic financial advisor.